Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Rothstein

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Expert Opinion on Investigational Drugs|January 31, 2003
Development potential of rifalazilDavid M Rothstein, Arthur D Hartman, Michael H Cynamon, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2008
Efficacy of benzoxazinorifamycins in a mouse model of Chlamydia pneumoniae lung infectionLee Ann Campbell, Cho-Chou Kuo, Robert J Suchland, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2004
Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerismGeoffrey Camirand, Joël Rousseau, Marie-Eve Ducharme, et al.
Expert Opinion on Investigational Drugs|May 31, 2006
Development potential of rifalazil and other benzoxazinorifamycinsDavid M Rothstein, Christo Shalish, Christopher K Murphy, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazilRobert J Suchland, Agnès Bourillon, Erick Denamur, et al.
Expert Opinion on Emerging Drugs|July 2, 2005
Histatin-derived peptides: potential agents to treat localised infectionsDavid M Rothstein, Eva J Helmerhorst, Peter Spacciapoli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 8, 2010
Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cellsDaniel Skuk, Martin Paradis, Marlyne Goulet, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 30, 2019
Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCsKanishka Mohib, Aravind Cherukuri, Yu Zhou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2009
An innate response to allogeneic nonself mediated by monocytesDaniel Zecher, Nico van Rooijen, David M Rothstein, et al.
The Journal of Antibiotics|November 11, 2008
Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniaeDavid M Rothstein, Robert J Suchland, Minsheng Xia, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|January 31, 2003
Development potential of rifalazilDavid M Rothstein, Arthur D Hartman, Michael H Cynamon, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2008
Efficacy of benzoxazinorifamycins in a mouse model of Chlamydia pneumoniae lung infectionLee Ann Campbell, Cho-Chou Kuo, Robert J Suchland, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2004
Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerismGeoffrey Camirand, Joël Rousseau, Marie-Eve Ducharme, et al.
Expert Opinion on Investigational Drugs|May 31, 2006
Development potential of rifalazil and other benzoxazinorifamycinsDavid M Rothstein, Christo Shalish, Christopher K Murphy, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazilRobert J Suchland, Agnès Bourillon, Erick Denamur, et al.
Expert Opinion on Emerging Drugs|July 2, 2005
Histatin-derived peptides: potential agents to treat localised infectionsDavid M Rothstein, Eva J Helmerhorst, Peter Spacciapoli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 8, 2010
Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cellsDaniel Skuk, Martin Paradis, Marlyne Goulet, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 30, 2019
Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCsKanishka Mohib, Aravind Cherukuri, Yu Zhou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2009
An innate response to allogeneic nonself mediated by monocytesDaniel Zecher, Nico van Rooijen, David M Rothstein, et al.
The Journal of Antibiotics|November 11, 2008
Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniaeDavid M Rothstein, Robert J Suchland, Minsheng Xia, et al.
Pageof 8